The 24th annual BIO-Europe will kick off on November 4th for three intense days of high level networking in Copenhagen. BIO-Europe is Europe´s largest biotech and pharma partnering conference. This year it will bring together more than 4,000 industry attendees from over 60 countries, representing more than 2,100 companies. And MedSIR will be right there in the thick of things!
Representatives from all echelons of the biotech and pharma industry attend BIO-Europe with the goal of establishing strategic relationships that will push their research and business plans forward, while all sharing the common goal of finding synergies to help patients live better and longer lives. In that spirit, the event itself consists of pre-arranged one-to-one meetings and a number of networking events.
Specifically, the MedSIR team will attend BIO-Europe with the goal of meeting potential partners seeking to develop new cancer therapies. These potential partners will include small biotechs, large pharma, local companies, American companies, and Asian companies, among others. We look very much forward to the possible synergistic partnerships looming in the horizon, partnerships that may translate into future practice-changing treatments for patients and their families.
Comments